|Day Low/High||62.17 / 62.64|
|52 Wk Low/High||45.28 / 62.48|
Jim Cramer says investors are migrating toward sectors likely to have the biggest upside in the second half.
The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a third quarter 2017 dividend payable to holders of the company's common stock of $0.
Speaking to shareholders at the Zoetis Inc. (NYSE:ZTS) annual meeting today in Short Hills, N.
Zoetis Inc. (NYSE:ZTS), the global leader in animal health, today announced that it has been named one of America's Best Midsize Employers by Forbes Magazine for the second year in a row.
Zoetis Inc. (NYSE:ZTS), the largest global animal health company, announced it will receive a US$14.
Gyrations hit market, as traders drop oil, buy safety.
The list begins with oil, but there's a ripple effect.
The Fed's intent is still as plain to see as it was late last year. This committee remains on mission.
Zoetis Inc. (NYSE:ZTS) today reported its financial results for the first quarter of 2017 and reaffirmed its guidance for full year 2017.
Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Merrill Lynch Health Care Conference on Wednesday, May 17, 2017, in Las Vegas, Nev.
Zoetis Inc. (NYSE:ZTS) today announced that the European Commission has granted the company marketing authorization for Cytopoint (lokivetmab), the first monoclonal antibody (mAb) therapy approved in the European...
Zoetis Inc. (NYSE:ZTS) and Nexvet Biopharma plc (Nasdaq:NVET) today announced an agreement in which Zoetis, through a wholly owned subsidiary ("Zoetis Bidco"), will purchase Nexvet, an innovator in monoclonal...
Zoetis Inc. (NYSE:ZTS), the leading global animal health company, today announced that music and television star Nick Lachey* is teaming up with the company to launch Your Animal Instinct , a program to help your...
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.
Jim Cramer is bullish on Halliburton, Schlumberger, Cypress Semiconductor and Celgene
Tech's organic growth and visibility has been apparent all year, says Jim Cramer.
The company hired Paul Bisaro, former chairman at Allergan, to become CEO as Morgan Stanley helps explore alternatives, including a sale.
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Zoetis Inc has taken over the #25 spot from Alphabet Inc , according to ETF Channel. Below is a chart of Zoetis Inc versus Alphabet Inc plotting their respective rank within the S&P 500 over time (ZTS plotted in blue; GOOGL plotted in green): In forming the rank, the analyst opinions from the major brokerage houses were tallied, and averaged; then, the underlying components were ranked according to those averages.
Zoetis Inc. (NYSE:ZTS) will participate in the Jefferies Animal Health Summit on Thursday, March 30, 2017, in New York, N.
In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Zoetis Inc has taken over the #193 spot from CBS Corp , according to The Online Investor. Market capitalization is an important data point for investors to keep an eye on, for various reasons.
Zoetis Inc. (NYSE:ZTS) will participate in the Cowen and Company 37th Annual Health Care Conference on March 6, 2017, in Boston, Mass.
The New Jersey-based animal health company reported better-than-expected fourth quarter earnings Thursday, but shares fell 5%.
The company lowered guidance for FY 2017, which is likely to blame for the company's fall.
Ackman launched a winning activist campaign at Chipotle last year.
The consumer finally has some fun money to spare. That is the good news.
Zoetis Inc. (NYSE:ZTS) today reported its financial results for the fourth quarter and full year 2016 and updated its guidance for the full year 2017.
Billionaire investors appear to see good times ahead with a fellow billionaire in the White House.
Zoetis Inc. (NYSE:ZTS) today announced that the European Commission has granted the company a license for Stronghold ® Plus (selamectin/sarolaner), a topical combination of parasiticides that treats ticks,...